Eisai to Launch Alzheimer's Drug Leqembi in Japan on December 20

Eisai Co., Ltd. announced on December 13 that it will begin selling the Alzheimer's drug Leqembi in Japan starting December 20. Eisai and its partner Biogen will co-promote the drug in Japan. On September 25 this year, the intravenous injection treatment for Alzheimer’s disease, Leqembi, jointly developed by Biogen and Eisai, was approved for marketing by Japan's Ministry of Health, Labour and Welfare. (Jiemian)Original link